Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Goodnow

Showing results (121-130 of 311) with videos related to

Pageof 32
Sort By:
Cell|October 18, 1996
Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptorJ C Rathmell, S E Townsend, J C Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987
Secretion of a chimeric T-cell receptor-immunoglobulin proteinN R Gascoigne, C C Goodnow, K I Dudzik, et al.
Immunity|August 1, 1997
A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitisS Akkaraju, W Y Ho, D Leong, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|June 6, 2018
Understanding Immune Tolerance of Cancer: Re-Purposing Insights from Fetal Allografts and MicrobesMegan B Barnet, Prunella Blinman, Wendy Cooper, et al.
Nature|February 25, 2000
How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesisR Glynne, S Akkaraju, J I Healy, et al.
Immunity|March 30, 2010
CD45-Csk phosphatase-kinase titration uncouples basal and inducible T cell receptor signaling during thymic developmentJulie Zikherman, Craig Jenne, Susan Watson, et al.
Immunology|November 26, 2013
A ZAP-70 kinase domain variant prevents thymocyte-positive selection despite signalling CD69 inductionOwen M Siggs, Adèle L Yates, Susan Schlenner, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
A monoclonal antibody with selectivity for human kappa myeloma and lymphoma cells which has potential as a therapeutic agentK Z Walker, H A Boux, G E Hayden, et al.
The Journal of Experimental Medicine|April 4, 1998
Spontaneous follicular exclusion of SHP1-deficient B cells is conditional on the presence of competitor wild-type B cellsK N Schmidt, C W Hsu, C T Griffin, et al.
Nature|October 24, 1991
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigensS B Hartley, J Crosbie, R Brink, et al.
Pageof 32

Showing results (121-130 of 311) with videos related to

Sort By:
Pageof 32
Cell|October 18, 1996
Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptorJ C Rathmell, S E Townsend, J C Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987
Secretion of a chimeric T-cell receptor-immunoglobulin proteinN R Gascoigne, C C Goodnow, K I Dudzik, et al.
Immunity|August 1, 1997
A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitisS Akkaraju, W Y Ho, D Leong, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|June 6, 2018
Understanding Immune Tolerance of Cancer: Re-Purposing Insights from Fetal Allografts and MicrobesMegan B Barnet, Prunella Blinman, Wendy Cooper, et al.
Nature|February 25, 2000
How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesisR Glynne, S Akkaraju, J I Healy, et al.
Immunity|March 30, 2010
CD45-Csk phosphatase-kinase titration uncouples basal and inducible T cell receptor signaling during thymic developmentJulie Zikherman, Craig Jenne, Susan Watson, et al.
Immunology|November 26, 2013
A ZAP-70 kinase domain variant prevents thymocyte-positive selection despite signalling CD69 inductionOwen M Siggs, Adèle L Yates, Susan Schlenner, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
A monoclonal antibody with selectivity for human kappa myeloma and lymphoma cells which has potential as a therapeutic agentK Z Walker, H A Boux, G E Hayden, et al.
The Journal of Experimental Medicine|April 4, 1998
Spontaneous follicular exclusion of SHP1-deficient B cells is conditional on the presence of competitor wild-type B cellsK N Schmidt, C W Hsu, C T Griffin, et al.
Nature|October 24, 1991
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigensS B Hartley, J Crosbie, R Brink, et al.
Pageof 32